Optimized Lung Cancer Prediction using Adaptive Federated Multimodal Transformer Framework with Self-Supervised Feature Evolution
| © 2026 by IJITS Journal |
| Volume-1 Issue-1 |
| Year of Publication : 2026 |
| Author : 1 Dr. R. Vidya*, 2 M. Amenraj |
| DOI : https://doi.org/10.64909/IJITS.2025.1103 |
Abstract
Early detection of lung cancer requires predictive systems capable of analysing complex and
heterogeneous medical data with high reliability. Conventional machine learning approaches
often depend on centralized datasets and static feature selection, limiting their adaptability in
distributed clinical environments. Objective: This study proposes a comprehensive multimodal
framework that integrates structured clinical records, radiological imaging features, genomic
mutation profiles and environmental exposure variables into a unified predictive architecture.
The methodology combines self-supervised representation learning, transformer-based crossmodal fusion, federated collaborative training and dynamic feature evolution to enhance
robustness and scalability. Methods: Self-supervised learning strengthens intrinsic feature
representations before supervised classification, improving generalization across diverse patient
groups. A transformer-based fusion mechanism captures interdependencies among modalities
through cross-attention operations, enabling patient-specific feature weighting. Federated
collaborative learning allows multiple institutions to train a shared global model without
exchanging raw medical data, preserving privacy while improving cross-hospital
generalization. In addition, a dynamic feature evolution strategy monitors distributional shifts
and adjusts feature importance to maintain long-term predictive stability. Results: Experimental
evaluation demonstrates superior performance compared to earlier hybrid ensemble models,
achieving improvements in accuracy, sensitivity and calibration reliability. The federated
configuration maintains stable performance across distributed datasets while reducing
institutional bias. The proposed framework offers a scalable and adaptive solution for realworld lung cancer screening and clinical decision support.

